Enzyme-Induction Dependent Bioactivation of Troglitazone and Troglitazone Quinone In Vivo

Plosker G. L., 1999, Troglitazone:  a review of its use in the management of type 2 diabetes mellitus. Drugs 57, 409−438, 10.2165/00003495-199957030-00014

Kohlroser J., 2000, Am. J. Gastroenterol., 95, 10.1111/j.1572-0241.2000.01707.x

Biswas P., 2001, Troglitazone and liver function abnormalities:  lessions from a prescription event monitoring study and spontaneous reporting. Drug Saf. 24, 149−154, 10.2165/00002018-200124020-00004

Gitlin N., 1998, Ann. Intern. Med., 129, 38, 10.7326/0003-4819-129-1-199807010-00008

Neuschwander-Tetri B. A., 1998, Ann. Intern. Med., 129, 41, 10.7326/0003-4819-129-1-199807010-00009

Murphy E. J., 2000, Troglitazone-induced fulminant hepatic failure. Dig. Dis. Sci. 45, 549−553

Isley W. L., 2000, Rosiglitazone and liver failure. Ann. Intern. Med. 133, 393−394

Bolton J. L., 2000, Role of quinones in toxicology. Chem. Res. Toxicol. 13, 135−160

Yamazaki H., 1999, Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metab. Dispos. 27, 1260−1266

Sahi J., 2000, Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes. Xenobiotica 30, 273−284

Kawai, K., Kawasaki-Tokui, Y., Odaka, T., Tsuruta, F., Kazui, M., Iwabuchi, H., Nakamura, T., Kinoshita, T., Ikeda, T., Yoshioka, T., Komai, T., and Nakamura, K.I. (1997) Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.Arzneimittelforschung47, 356−368.

Harris R. Z., 1999, J. Clin. Pharmacol., 39, 10.1177/009127009903901112

Jayyosi Z., 1999, Proceedings of the 9th North American ISSX Meeting, no. 398

Kassahun K., 2001, Chem. Res. Toxicol., 14, 70, 10.1021/tx000180q

Kawai, K., Hirota, T., Muramatsu, S., Tsuruta, F., Ikeda, T., Kobashi K., and Nakamura, K.I. (2000) Intestinal absorption and excretion of troglitazone sulphate, a major biliary metabolite of troglitazone.Xenobiotica30, 707−715.

Kostrubsky V. E., 2000, The role of conjuagation in hepatotoxicity of troglitazone in human and porcine hepatocyte cultures. Drug. Metab. Dispos. 28, 1192−1197

Yoshigae Y., 2000, J. Toxicol. Sci., 25, 10.2131/jts.25.5_433

Watanabe M., 1998, Effects of glucocorticoids on pharmacokinetics and pharmacodynamics of midazolam in rats. Life Sci. 63, 1685−1692

Yoshioka T., 1991, Chem. Abstr., 115, 183286h

Maggs J. L., 1995, J. Pharmacol. Exp. Ther., 275

Moldeus P., 1978, Methods Enzymol., 60, 65

Tettey J. N., 1999, Intracellular localization and metabolism of the phenanthridinium trypanocide, ethidium bromide, by isolated rat hepatocytes. Xenobiotica 29, 349−360

Ham A.-J. L., 1995, Vitamin E oxidation in rat liver mitochondria. Biochemistry 34, 5754−5761

Satoh H., 2000, Drug Metab. Rev., 32, 204

Fuhr U., 2000, Induction of drug metabolising enzymes:  pharmacokinetic and toxicological consequences in humans. Clin. Pharmacokinet. 38, 493−504, 10.2165/00003088-200038060-00003

Goeptar, A. R., te Koppele, J. M., Neve, E. P. A., and Vermeulen, N. P. E. (1992) Reductase and oxidase activity of rat liver cytochrome P450 with 2,3,5,6-tetramethylbenzoquinone as substrate.Chem.Biol. Interact.83, 249−269.

Goeptar, A. R., te Koppele, J. M., van Maanen, J. M. S., Zoetemelk, C. E. M., and Vermeulen, N. P. E. (1992) One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.Biochem. Pharmacol.43, 343−352.

Kiyose C., 1999, Simultaneous determination of RRR- and SRR-alpha-tocopherols and their quinones in rat plasma and tissues by using chiral high-performance liquid chromatography. Lipids 34, 415−422

Vatassery G. T., 1987, Determination of alpha-tocopherolquinone (vitamin E quinone) in human serum, platelets, and red cell membrane samples. Anal. Biochem. 167, 411−417

Neuzil J., 1997, Proc. Natl. Acad. Sci. U.S.A. 94

Hayashi T., 1992, Reduction of alpha-tocopherolquinone to alpha-tocopherolhydroquinone in rat hepatocytes. Biochem. Pharmacol. 44, 489−493

Skett P., 1994, Vitro 8, 491−504.

Hoen P. A. C., 2000, Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes:  analysis with a novel reverse transcriptase-polymerase chain reaction assay. Biochem. Pharm. 60, 1509−1518

Lauriault V. V., 1990, Arch. Biochem. Biophys., 282, 33, 10.1016/0003-9861(90)90082-A

Kamal-Eldin A., 1996, The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31, 671−701

Cornwell D. G., 1998, Cytotoxicity of tocopherols and their quinones in drug-sensitive and multidrug-resistant leukemia cells. Lipids 33, 295−301

Rossi L., 1986, Arch. Biochem. Biophys., 251, 35, 10.1016/0003-9861(86)90047-0

Kitteringham N. R., 2000, Hepatocellular response to chemical stress in CD-1 mice:  induction of early genes and gamma-glutamylcysteine synthetase. Hepatology 32, 321−333

Castell J. V., 1997, The use of cultured hepatocytes to investigate the mechanisms of drug hepatotoxicity. Cell Biol Toxicol 13, 331−338

Abbreviations TGZ, troglitazone